CN1147237C - Chinese-medicinal feed for layers - Google Patents
Chinese-medicinal feed for layersInfo
- Publication number
- CN1147237C CN1147237C CNB011282509A CN01128250A CN1147237C CN 1147237 C CN1147237 C CN 1147237C CN B011282509 A CNB011282509 A CN B011282509A CN 01128250 A CN01128250 A CN 01128250A CN 1147237 C CN1147237 C CN 1147237C
- Authority
- CN
- China
- Prior art keywords
- content
- egg
- eggs
- feed
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 5
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 5
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 4
- 235000005412 red sage Nutrition 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 13
- 239000000654 additive Substances 0.000 claims description 7
- 230000000996 additive effect Effects 0.000 claims description 7
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 235000013601 eggs Nutrition 0.000 abstract description 24
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 9
- 239000011707 mineral Substances 0.000 abstract description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 8
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract description 4
- 239000011575 calcium Substances 0.000 abstract description 4
- 229910052791 calcium Inorganic materials 0.000 abstract description 4
- 235000005473 carotenes Nutrition 0.000 abstract description 4
- 239000011630 iodine Substances 0.000 abstract description 4
- 229910052740 iodine Inorganic materials 0.000 abstract description 4
- 229910052742 iron Inorganic materials 0.000 abstract description 4
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 abstract description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract description 3
- 239000011574 phosphorus Substances 0.000 abstract description 3
- 229910052698 phosphorus Inorganic materials 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 229910052732 germanium Inorganic materials 0.000 abstract description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052711 selenium Inorganic materials 0.000 abstract description 2
- 239000011669 selenium Substances 0.000 abstract description 2
- 150000001746 carotenes Chemical class 0.000 abstract 2
- 229940126678 chinese medicines Drugs 0.000 abstract 2
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 8
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 239000002075 main ingredient Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 2
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 206010044278 Trace element deficiency Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- GLXGDSIDFQEZRG-UHFFFAOYSA-N [Ca].[I] Chemical compound [Ca].[I] GLXGDSIDFQEZRG-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- -1 carotene carotene Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
Abstract
The present invention provides laying hen feed with Chinese medicines in the field of animal feed. The added Chinese medicines comprise safflower, Chinese wolfberry, keel and red sage root which are proportionally mixed with the laying hen feed. The living activity and the metabolizing capability of laying hens are enhanced according to the proof of feeding the hens, the content of carotene and main mineral in laid eggs is more than that in common eggs, wherein the carotene has the more content of 1.64 ug/g, phosphorus has the more content of 0.097%, calcium has the more content of 0.192.89 ug/g, iron has the more content of 17.73 ug/g, iodine has the more content of 3.29 mg/100g, and germanium and selenium are also contained. The content of amino acid is greatly increased, and the total quality of the amino acid reaches 29114.2 mg/100g. The quality and the taste of eggs are also greatly enhanced.
Description
Technical field
What the present invention relates to is field of animal feed, specifically is added with the Chinese medicine egg feedstuff of Chinese medicine.
Background technology
Before the present invention proposed, the someone passed through in the chicken feed to add mineral matters such as iodine calcium and rare earth microelement, made the egg of chicken output be rich in certain or several mineral materials, for example, added the high-iodine eggs of salt compounded of iodine in the chicken feed, and what add calcium salt is the high calcium egg.The egg that this certain element surpasses normal amount can more effectively be the additional mineral element of the person's of eating human body, thereby overcomes mineral matter or trace element deficiency.
Though the chicken of this forage feed by adding the mineral raw material under egg in egg, increased mineral matter, but significantly do not improve on the quality of egg, especially the amount of total amino acid content and vitamin and special mineral matter and ratio equilibrium problem are not obviously improved.
Summary of the invention
The purpose of this invention is to provide a kind of prescription that is added with the egg feedstuff of Chinese herbal medicine, make the egg quality that chicken produced of edible this feed good, the nutriment height.
Particular content is to be mixed in proportion by Chinese medicine additive and egg feedstuff.
Chinese medicine additive by the weighing in proportion of safflower, matrimony vine, the red sage root, keel, pulverize, be mixed into Powdered.
To add Chinese medicine as follows to the pharmacological action of human body:
Safflower: Main Ingredients and Appearance: carthamin yellow and carthamin
Function: promoting blood circulation, stimulate the menstrual flow.
Cure mainly: 1, prevention cardiovascular and cerebrovascular disease,
2, to cerebral embolism, venous embolism plays therapeutic action,
3, facial macula is played the elimination effect.
Matrimony vine: Main Ingredients and Appearance: LBP-X, 18 seed amino acids, trace element and organic germaniums such as Hu Luoka element and calcium, iron, phosphorus, lithium have healthcare, suppress human cancer cell's diffusion, strengthen the anti-ageing function of body immunity.
Nourishing liver and kidney, production of sperm benefit gas is controlled void and is calmed the nerves, and beneficial blood makes eye bright, and moistening lung is anticancer, promotes longevity.
The red sage root: Main Ingredients and Appearance: vitamin E
Function: the rash of invigorating blood circulation, dispel, cool blood disappear bitterly, nourishing blood and tranquilization.
Cure mainly: 1, menoxenia, the stasis of blood stagnated and suffered from abdominal pain postpartum, gather,
2, sore, carbuncle and painful swelling,
3, palpitation and insomnia, tranquilizing and blood nourishing,
4, lung splenomegaly and coronary heart disease, angina pectoris etc.
Keel: Main Ingredients and Appearance: calcium carbonate, calcium phosphate, iron, potassium, sodium, chlorine, sulfate radical etc.
Function: flat liver, checking exuberance of yang, tranquilizing and allaying excitement, convergence are astringent or styptic treatment for spontaneous sweating.
Cure mainly: 1, have a dizzy spell, vexed dry anger, there is therapeutic action climacteric,
2, invigorate the kidney and stop nocturnal emission.
Tentative feeding by feed of the present invention raised, and chicken produced the egg random sampling carry out assay, compares its carrotene and main useful content of mineral substances such as following table with common egg:
Carrotene and mineral matter analytical table
By comparative analysis as can be seen carotene carotene content rise to:
(1.95-0.31)=1.64ug/g
Phosphorus is: (0.274-0.177)=0.097%
Calcium is: (563.34-370.45) * and 100%=192.89ug/g
Iron is: (30.96-13.23)=and 17.73ug/g
Iodine is: (6.27-2.98)=and 3.29mg/100g
Selenium is: 5.02ug/kg, and the contrast egg does not detect
Germanium is: 6.73ug/kg, and the contrast egg does not detect
Simultaneously, the egg that feeds Chinese medicine additive chicken feed has been carried out amino acid whose analysis, its result is as follows:
Amino acid analysis is table as a result
4 | Glutamic acid | 5916.3 | Mg/100g |
5 | Glycine | 657.4 | Mg/100g |
6 | Alanine | 576.5 | Mg/100g |
7 | Cystine | 212.8 | Mg/100g |
8 | Valine | 1210.6 | Mg/100g |
9 | Methionine | 1609.8 | Mg/100g |
10 | Isoleucine | 1140.0 | Mg/100g |
11 | Leucine | 2157.8 | Mg/100g |
12 | Tyrosine | 1011.6 | Mg/100g |
13 | Phenylalanine | 1300.2 | Mg/100g |
14 | Lysine | 1387.9 | Mg/100g |
15 | Histidine | 1813.5 | Mg/100g |
16 | Arginine | 1287.8 | Mg/100g |
17 | Proline | 1350.4 | Mg/100g |
18 | Tryptophan | 237.0 | Mg/100g |
Amount to | 29114.2 | Mg/100g |
The sense index performance: yolk is salmon pink, and the egg white denseness is big.When edible, egg is raw meat not, and yolk is not filled in larynx, and pure taste is agreeable to the taste.
The specific embodiment
1, the preparation of Chinese medicine additive
Get dry salviamiltiorrhizabung, safflower, matrimony vine, each 1-50g ratio of keel of not going mouldy and pulverize mixing respectively, make Chinese medicine additive.
2, the manufacturing of Chinese medicine egg feedstuff
100 parts of the egg feedstuffs that choosing is fit to corresponding kind chicken add Chinese medicine additive 0.01-0.05 part, after mixing, and damp-prrof packing and become egg feedstuff of the present invention.
Suitable hello chicken order is between 200-400 day makes.
Claims (1)
1, a kind of egg feedstuff that is added with Chinese medicine is characterized in that, adds in 100 parts of egg feedstuffs by safflower, matrimony vine, the red sage root, each 1~50 gram of keel and pulverizes 0.01~0.05 part of the Chinese medicine additive that is mixed and made into.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011282509A CN1147237C (en) | 2001-09-30 | 2001-09-30 | Chinese-medicinal feed for layers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011282509A CN1147237C (en) | 2001-09-30 | 2001-09-30 | Chinese-medicinal feed for layers |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1343454A CN1343454A (en) | 2002-04-10 |
CN1147237C true CN1147237C (en) | 2004-04-28 |
Family
ID=4668126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011282509A Expired - Fee Related CN1147237C (en) | 2001-09-30 | 2001-09-30 | Chinese-medicinal feed for layers |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1147237C (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20041631A1 (en) * | 2004-08-06 | 2004-11-06 | Indena Spa | USE OF MEDICINALIME PLANTS OF THEIR EXTRACTS AS PROMOTERS OF GROWTH IN VETERINARY AND ZOOTECHNY |
CN1868302B (en) * | 2005-05-23 | 2010-09-01 | 河南省金鑫饲料工业有限公司 | Chinese herb medicine additive for chicken feed |
CN101213953B (en) * | 2008-01-15 | 2010-06-30 | 济南康众医药科技开发有限公司 | Method for breeding chick |
CN102342377B (en) * | 2011-09-08 | 2013-02-13 | 张臣 | Chinese herbal medicine laying hen feed |
CN103621770A (en) * | 2013-10-26 | 2014-03-12 | 铜陵市银树生态养殖有限责任公司 | Laying hen feed containing cinnamomum camphora seeds |
CN105285451A (en) * | 2015-11-04 | 2016-02-03 | 成都心连心农业有限公司 | Compound feed additive for laying hens and preparation method of compound feed additive |
-
2001
- 2001-09-30 CN CNB011282509A patent/CN1147237C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1343454A (en) | 2002-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108095072A (en) | Small peptide spy's dietary seafood formula is eaten for long-term bed and muscle attenuation syndrome crowd | |
CN105614860A (en) | Probiotic compound oligopeptide nutritional supplement capable of lowering uric acid | |
CN1147237C (en) | Chinese-medicinal feed for layers | |
CN1843156A (en) | Purple common perilla seed feedstuff additive and preparation method thereof | |
CN105918387A (en) | Healthcare food suitable for middle aged and elderly people and preparation method thereof | |
DE102008064588A1 (en) | Nutritional supplement based on pantothenic acid | |
CN1083365A (en) | North aweto nourishing wine and preparation method thereof | |
CN102845361A (en) | Method for raising selenium-rich meiling sheep | |
US20040052871A1 (en) | Health enhancement system | |
CN107712414A (en) | A kind of chicken feed for improving resistance | |
CN1204825C (en) | Additive of fowl feed and its resultant health-care eggs rich in I, Se and Zn and containing less cholesterol | |
CN1116925A (en) | Cod liver oil emulsion and its preparation | |
CN100336893C (en) | Pumpkin red cordial and its brewing process | |
CN103690564A (en) | Application of wood frog high protein calcium powder in preparation of anti-fatigue health-care products or drugs | |
CN1895293A (en) | Spirulina oral tablet for supplementing human-body nutrients and its preparation | |
RU2653549C2 (en) | Method of increasing the productive quality of laying hens and consumer properties of produced products (eggs) | |
EP4044824A1 (en) | Nutritional supplement | |
CN105168482B (en) | It is a kind of for treating the composite bacterium powder of canker sore | |
CN109198648A (en) | Golden worm cancer liberator base enzyme peptide | |
RU2534307C2 (en) | Composition of biologically active feed additive for laying hens | |
RU2148942C1 (en) | Biologically-active food additive | |
CN116210898A (en) | Compound fungal polysaccharide product for regulating glycolipid metabolism through immune activation | |
RU2351350C1 (en) | Set "predstar", its application and method of prevention of premature organism aging | |
RU2658431C1 (en) | Dry nutritional formula for dietary nutrition | |
CN1279027A (en) | Egg and chicken containing ginseng saponin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040428 Termination date: 20100930 |